Stock BCAB BIOATLA, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Relative Strength Chart BioAtla, Inc.

Equities

BCAB

US09077B1044

Market Closed - Nasdaq
Other stock markets
 21:00:00 14/05/2024 BST 		5-day change 1st Jan Change
2.61 USD -1.14% Intraday chart for BioAtla, Inc. -15.53% +6.10%
05-06 BioAtla's Multiple Cancer Drug Candidate Receives FDA Clearance MT
05-06 BioAtla Announces FDA Clearance of Investigational New Drug Application for BA3361, a CAB-Nectin-4 Antibody Drug Conjugate for the Treatment of Multiple Tumors CI

End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
BIOATLA, INC.
Other Biotechnology & Medical Research
-1.14%-15.53%+6.10%-28.88% - 127M
Neutral
Neutral
Neutral
  1. Stock Market
  2. Equities
  3. BCAB Stock
  4. Charts BioAtla, Inc.
  5. Relative Strength Chart